TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: percentage of time spent in Spo2 <80%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: number of prolonged episodes (>60 s) of Spo2 <80% per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: LV functions improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: hepatic cytolysis
Endpoint domain: Adverse events/effects
Primary endpoint: dermatitis/rash
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in goal performance and satisfaction
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Foot and Ankle Ability Measures-sports subscale improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiopulmonary endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global motor outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global non‐motor symptoms outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self Exercise Efficacy Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiological Function Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life and function scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Small for Gestational Age (SGA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Stillbirth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: everyday cognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Odds ratio for worse outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACT total score ≥20 or improvement of >3 points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in ACT total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in CEA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean vessel size improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Investigator GAI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated blood loss and transfusion requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Labor cost for OB Nest prenatal care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Performance degradation and recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visceral adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hot Flash Related Daily Interference scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: postoperative average hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: recurrence of dysphagia at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shorter waiting time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of long glances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standard deviation of lane position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of collisions and near-collisions
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in lung clearance index2.5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of patients whose renal function returned to baseline after AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in calculated glomerular filtration rate from admission to discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Complications of AKI (e.g., hyperkalemia, pulmonary edema, renal acidosis)
Endpoint domain: Adverse events/effects
Primary endpoint: Liver steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Gonadal adipose tissue weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cumulative rate of repair for re-recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of moderate/severe AAS-pain
Endpoint domain: Adverse events/effects
Primary endpoint: improvement in resting cardiac autonomic control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: monoexponential T2 *
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fractional order T2 *
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of short T2 * components
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neck and shoulder stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disease knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical activity intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unified Parkinson's Disease Rating Scale motor score area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Finger-tapping speeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Dyskinesia scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean power output during TT15'
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of PEP in high risk patients
Endpoint domain: Adverse events/effects
Primary endpoint: long-term adherence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Improved carbon monoxide levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in blood flow velocities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lower post‐treatment MADRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak center of pressure velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: belief change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mortality and rehospitalization risk
Endpoint domain: Mortality/survival
Primary endpoint: attentional set-shifting
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: early preterm birth
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in parent-adolescent communication on ACP themes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change in CORE-OM score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Unified Parkinson's Disease Rating Scale total and motor scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients feeling much to very much better
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concentration of chemokines (IL-8, CCL3, CCL4, CCL5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Systemic concentration of growth factors (bFGF, PDGF-BB, IL-7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Requests for PO analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: consecutive eGFR levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: risk of nephrotoxicity (acute kidney injury)
Endpoint domain: Adverse events/effects
Primary endpoint: Positive predictive value of EoE diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: apolipoprotein B (Apo B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: hemoglobin and hematocrit postoperative value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Treatment failures by 28 days
Endpoint domain: Adverse events/effects
Primary endpoint: Global aesthetic improvement scale (GAIS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cellulite severity scale (CSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subject satisfaction questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pressure Pain Threshold (PPT) improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for additional stitches
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Frailty scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative recurrent instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of revision surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: perceived benefits of treatment interventions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: changes in family or professional life
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: group participation and social interactions
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Crude rate of stroke events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: VTE recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death or disability at 3 months postrandomization
Endpoint domain: Mortality/survival
Primary endpoint: Overjet correction success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ANB correction success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PVC-burden reduction of ≥80%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mapping success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage decline in fasting plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage decline in HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ischemia-driven target lesion revascularization
Endpoint domain: Adverse events/effects
Primary endpoint: RAPID3 improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAQ-Disability Index improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Seattle Angina Questionnaire (SAQ) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in Pro-inflammatory Load (IL-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Loss to follow-up (LTFU)
Endpoint domain: Mortality/survival
Primary endpoint: Satisfaction with specific body parts
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Drive for muscularity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Supplement use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Sensitivity for the detection of cannabis use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: persistent problems after hospitalization
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: MBI scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain after total knee arthroplasty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall scores of MoCA-B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: N5 and N7 scores of AVLT-H
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: STTB scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: McGill scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change of sore throat score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of patients reporting moderate or greater impact on daily life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: propulsion symmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: paretic propulsive impulse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: in vivo release of TFV from IVR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median VF TFV concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: in vitro HIV-1 inhibition by VF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in dementia-related stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in dementia knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: medication administration error rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interruption rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective proprioception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma choline levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma betaine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TMAO levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from AF/AT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of food consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Willingness to participate in an RCT
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SDAI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 1 Neuropathy
Endpoint domain: Adverse events/effects
Primary endpoint: plasma dp-ucMGP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mRNA levels of PGC1A and PDK4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: IL-6 increase from 45 to 90 min post-recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of appropriate follow-up completion
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Rate of no follow-up despite indications
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: primary efficacy renal response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: complete renal response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: risk of renal-related event or death
Endpoint domain: Mortality/survival
Primary endpoint: PSA relapse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fracture of filter struts
Endpoint domain: Adverse events/effects
Primary endpoint: Adherent fibrous endothelial tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived trustworthiness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: VAS-anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maternal morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Vaccine hesitancy reduction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 30-second sit-to-stand test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum hs‐cTnT concentration after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of postoperative myocardial injury (PMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Calcium score PSN for obstructive CAD prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Functional Outcomes of Sleep Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: effectiveness of platinum combination chemotherapy with nivolumab plus ipilimumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gut functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction of BZD prescriptions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fewer long-term users of BZD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported information needs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complications (idiopathic vitritis, choroidal detachment, new glaucoma)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean MRD1 after anesthetic exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-anesthetic palpebral fissure height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of stay per hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Adjusted mean costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Modified CMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of alveolitis
Endpoint domain: Adverse events/effects
Primary endpoint: Knee flexion difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patellar fracture incidence
Endpoint domain: Adverse events/effects
Primary endpoint: anal continence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: postoperative wound healing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ΔSE/ΔAL with SVCL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SALAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central stromal reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GIQLI questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in diarrhoea episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Increased hand washing frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognition Z score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Word List Recall performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Word List Learning performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of fungal colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Safety profile of EB
Endpoint domain: Adverse events/effects
Primary endpoint: Tramadol hydrochloride consumption at 24 h after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients needing postoperative analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores of the patients after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between GAT IOP measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repeatability of ORA IOPg measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance of CCTA with ICA for significant CAD identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: fat body mass reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDS‐UPDRS Motor III clinical ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: days abstinent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reducing TV time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduced capacity for lipopolysaccharide-induced inflammatory cytokine production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Acceptability of universal screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: client-related burnout
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Incidence of AC (Adverse Events)
Endpoint domain: Adverse events/effects
Primary endpoint: Median stroke onset time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: sural nerve injury
Endpoint domain: Adverse events/effects